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Baeyer-Villiger monooxygenases (BVMOs) are ﬂavin-containing
and NAD(P)H-dependent enzymes that catalyze the incorporation
of one oxygen atom into organic substrates.1 BVMOs have recently
been shown to be excellent alternatives for performing the oxida-
tion of aldehydes and ketones to their corresponding esters, the
oxygenation of heteroatoms (sulfur, nitrogen, phosphorus, boron,
and selenium) and even epoxidation reactions.2 In many of these
reactions, the transformation of the substrates occurs with high
enantio- and/or regioselectivity, using environmentally friendly
conditions.3 Cyclohexanone monooxygenase (CHMO), which is
one of the most studied BVMOs, has a broad substrate acceptance
and displays moderate thermostability.4 In contrast, phenylace-
tone monooxygenase (PAMO) is remarkably stable but is limited
in substrate range by its preference for aromatic compounds. From
this BVMO, a mutant that has an altered substrate acceptance pro-
ﬁle has been generated (M446G PAMO), and accepts a different
range of aromatic ketones and aldehydes while retaining thermo-
stability. 4-Hydroxyacetophenone monooxygenase (HAPMO)3d,5,6
is another BVMO that has been shown to be effective in converting
aromatic ketones.
Recently, we described the ﬁrst example of the kinetic resolu-
tion of boron-containing chiral compounds mediated by PAMO.7
We have been studying boron-containing compounds because they
are known to be versatile intermediates in organic synthesis. The
C–B bond can be easily oxidized leading to the release of boron
and the formation of a C–O bond, resulting in alcohols, aldehydes,
or ketones, among other reactions.8 Additionally, chiral organobo-
ron compounds are especially important in organic synthesis, sincell rights reserved.
x: +55 11 3815 5579.
.they can be converted into other functional groups with retention
of conﬁguration and used as chiral catalysts.9
Based on previous reports of the selectivity of BVMO and the
importance of boron compounds in organic synthesis, herein we
explore the enantioselectivity of BVMOs for oxidative kinetic
resolutions of chiral organoboron compounds (Fig. 1).
2. Results and discussion
2.1. Synthesis of boron substrates for the evaluation of the
enantioselectivity of BVMOs
The set of chiral boron substrates studied is shown in Figure 1.
The organoboron compounds were synthesized according to
Figure 2.
2.2. Evaluation of the enantioselectivity of BVMOs via boron
oxidation
Motivated by our previous result, in which 1-phenylethyl bor-
onate 1a was submitted to oxidative kinetic resolution mediated
by PAMO (Table 1, entry 1),8 we performed the kinetic resolution
of 1a and other boron-containing aromatic compounds 1b and
1c by using PAMO, M446G PAMO, CHMO, and HAPMO (Table 1).
In these reactions we used a cofactor regenerating system by
applying phosphite dehydrogenase (PTDH) and a sacriﬁcial
substrate (phosphite).
We observed that in all cases CHMO and HAPMO led to the
decomposition of the starting material with no desired product
being observed. PAMO only mediated the kinetic resolution of 1a
(E = 33, Table 1, entry 1). Conversely, M446G PAMO mediated the
oxidation reaction of 1a (1-phenylethyl boronate, E = 9.9) and 1b
(4-methoxy-1-phenylethyl boronate, E = 2.8), but no conversion
















a) LDA, THF, (EtO)2P(O)Cl; b) TMSCl, NaI, H2O, CH2Cl2; c) B2Pin2, Pd(PPh3)2Cl2, PhOK, PPh3, toluene;









g) CH2I2, CH2Cl2, Et2Zn
f
f) CuCl, NaOt-Bu, DPEphos, B2Pin2, MeOH, THF
c
1a, R = H
1b, R = OMe
1c, R = F
3a, R = Me, R1= Me
3b, R = Me, R1= Et
3c, R = Me, R1= n-Bu
3d, R = Me, R1= Bn
3e, R = Ph, R1= Et
5a, R1 = H, R2 = Ph, R3 = H
5b, R1 = Ph, R2 = H, R3 = H















3a, R = Me, R1= Me
3b, R = Me, R1= Et
3c, R = Me, R1= n-Bu
3d, R = Me, R1= Bn





1a, R = H
1b, R = OMe
1c, R = F
5a, R1 = H, R2 = Ph, R3 = H
5b, R1 = Ph, R2 = H, R3 = H
5c, R1 = H, R2 = H, R3 = Ph
Figure 1. Boron-containing substrates used for the evaluation of the enantioselectivity of BVMOs in an oxidative kinetic resolution process.
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C–B bond mediated by a monooxygenase occurs with retention
of conﬁguration, similar to non-enzymatic oxidations, resulting
in the formation of the alcohol derivatives.10 PAMO and M446G
PAMO reacted both with the (S)-enantiomer leading to the
(S)-alcohol and the (R)-boronic ester.
We also explored the oxidation reaction of b-boronated
carboxylic esters to give b-hydroxy carboxylic esters. b-Hydroxy
carboxylic esters are highly attractive synthetic targets due to
their versatility in organic chemistry. Additionally, optically activeb-hydroxy carboxylic acids are important and interesting building
blocks for the synthesis of biologically active compounds.11
The results obtained with PAMO (Table 1) led us to evaluate the
kinetic resolution of b-boronated carboxylic esters 3a–e mediated
by this monooxygenase (Scheme 1).
Unfortunately, compounds 3a–bwere not stable in the Tris-buf-
fer, and even with no enzyme in the reaction medium, we observed
a decomposition of starting material. On the other hand, com-
pounds 3c–e were stable under the reaction conditions but again
no reaction was observed.
Table 1









































M446G PAMO 24 ()b ()c ()c
a Tris buffer 50 mM pH 7.5, DMSO (1%), substrate (10 mM), phosphite (20 mM), PTDH (1 lM), NADPH (0.2 mM), and BVMO (4 lM).
b No reaction was observed.
c No enantiomeric excess was observed.
P. B. Brondani et al. / Tetrahedron: Asymmetry 23 (2012) 703–708 705We also carried out the kinetic resolution of cyclopropyl
boronic esters 5a–c (Table 2). In addition to the importance of
boron-containing substrates, cyclopropyl compounds are versatile
building blocks in the synthesis of natural products due to their
well-deﬁned three-dimensional structures.12
We used three cyclopropyl derivatives with different geome-
tries. CHMO was unable to perform the oxidation of any of these
compounds 5a–c. Conversely, PAMO, M446G PAMO, and HAPMO
catalyzed the reaction, but with no enantioselectivity regardless
of geometry. Even with the phenyl moiety close to the boronic
ester moiety 5c, no enantioselectivity was observed.3. Conclusion
We have shown that PAMO was able to oxidize aromatic boron
compounds with no substituent in the aromatic ring with great
enantioselectivity. It could also be used to convert cyclopropyl
derivatives but with no enantioselectivity. PAMO was unable to
oxidize 1-phenylethyl boronates with substituents on the aromatic
ring (4-OMe and 4-F) apart from b-borylated carboxylic esters. The
mutant M446G PAMO showed a similar substrate acceptance, but
this BVMO displayed a lower enantioselectivity. We observed that




3a, R = Me, R1= Me
3b, R = Me, R1= Et
3c, R = Me, R1= n-Bu
3d, R = Me, R1= Bn













Scheme 1. Attempts to promote the oxidative kinetic resolution of b-boronated carboxylic esters 3a–e mediated by PAMO.
706 P. B. Brondani et al. / Tetrahedron: Asymmetry 23 (2012) 703–708no enantioselectivity. CHMO was unable to oxidize any of the
tested substrates. We can conclude that the substituent on the
aromatic ring of 1-phenylethyl boronates affects the performance
of PAMO and M446G PAMO. Moreover, cyclopropyl boronic esters
were efﬁciently oxidized to cyclopropyl alcohols by PAMO, M446G
PAMO, and HAPMO, but no enantioselectivity was observed.
4. Experimental
4.1. General
Recombinant phenylacetone monooxygenase (PAMO) from
Thermobiﬁda fusca, M446G PAMOmutant, 4-hydroxyacetophenone
monooxygenase (HAPMO) from Pseudomonas ﬂuorescens and
cyclohexanone monooxygenase (CHMO) from Acinetobacter sp.
were overexpressed and puriﬁed as previously described.13
Phosphite dehydrogenase was obtained as described before.14
Phosphite and NADPH were purchased from Sigma–Aldrich.
High performance liquid chromatography (HPLC) analyses for
measurement of enantiomeric excesses were performed on a Shi-
madzu (diode array detector SPD-M1OA, auto injector SIL-10AD e
Column Oven CTO-10A).
4.2. Synthesis of 4,4,5,5-tetramethyl-2-(1-phenylethyl)-1,3,2-
dioxaborolane compound 1a15
This compound was synthesized according to the literature.15
Clear oil, 80%. 1H NMR (200 MHz, CDCl3):d 1.19–1.35 (m, 15H),
2.36–2.46 (m, 1H), 7.12–7.26 (m, 5H). 13C NMR (50 MHz, CDCl3):
d 16.99, 24.54, 24.58, 83.26, 125.02, 127.74, 128.24, 144.92. LRMS
(EI) m/z (%) = 232 (M+, 60), 217(28), 174(14), 146(22), 132(74),
117(30), 105(100), 91(14), 83(64), 77(15), 59(10). FT-IV (ﬁlm,
cm1) mmax: 3065, 3029, 2981, 1459, 1351, 1146.
4.3. Synthesis of 2-[1-(4-methoxyphenyl)ethyl]-4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolane 1b16
The intermediate diethyl 1-(4-methoxyphenyl)vinyl phosphate
was synthesized according to the literature.16a Orange oil, 75%. 1H
NMR (200 MHz, CDCl3): d 1.34 (t, J = 7.2 Hz, 6H), 3.82 (s, 3H), 4.07–
4.20 (m, 4H), 5.10–5.17 (m, 2 H), 6.88 (d, J = 9 Hz, 2 H), 7.52
(d, J = 9 Hz, 2 H). 13C NMR (50 MHz, CDCl3): d 16.04, 25.47, 55.18,
64.28, 64.40, 95.36, 113.56, 122.27, 126.50, 152.05, 160.11. The
intermediate iodide was synthesized according to the literature16d
and used without puriﬁcation in the coupling reaction, which was
carried out according to the literature16e,f to give 2-[1-(4-methoxy-
phenyl)vinyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Clear oil,
83%. 1H NMR (200 MHz, CDCl3): d 1.29 (s, 12 H), 3.77 (s, 3H),
5.94 (d, J = 2.8 Hz, 1H), 5.99 (d, J = 2.6 Hz, 1H), 6.8 (d, J = 8.6 Hz,
2H), 7.17 (d, J = 8.6 Hz, 1H), 7.42 (d, J = 8.8 Hz, 1H). 13C NMR
(50 MHz, CDCl3): d 24.77, 55.20, 83.69, 112.08, 113.56, 128.21,158.80. The reduction of the vinyl boronic ester was carried out
in a similar way to procedures described in section 4.2 to give
2-[1-(4-methoxyphenyl)ethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane 1b. Yellow oil,90%. 1H NMR (200 MHz, CDCl3): d 1.12 (s, 12H),
1.24 (s, 3H), 2.28 (q, J = 7.8 Hz, 1H), 3.70 (s, 3 H), 6.70–7.14 (m, 4H).
13C NMR (50 MHz, CDCl3): d 17.33, 24.57, 55.16, 83.18, 113.74,
128.58, 136.99, 157.22. LRMS (EI) m/z (%) = 286 (M+, 4), 206 (5),
178 (4), 151(3), 136 (18), 135 (100), 134 (20), 121 (12), 119 (12),
105 (9), 103 (8), 91 (20), 77 (16), 65 (8). FT-IV (ﬁlm, cm1) mmax:
3004, 2919, 1661, 1437, 1407, 1316, 1021.
4.4. Synthesis of 2-[1-(4-ﬂuorophenyl)ethyl]-4,4,5,5-tetrame-
thyl-1,3,2-dioxaborolane 1c8,17
The intermediate iodide was synthesized according to the liter-
ature16a and used without puriﬁcation in the coupling reaction,
which was carried out according to the literature16e,f to give
2-[1-(4-ﬂuorophenyl)vinyl]-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane. Yellow solid, 60%. 1H NMR (200 MHz, CDCl3): d 1.25 (s, 12H),
6.88–6.98 (m, 2H), 7.36 (d, J = 5.4 Hz, 2H), 7.40 (d, J = 5.6 Hz, 2H).
13C NMR (50 MHz, CDCl3): d 24.86, 83.95, 114.79, 115.22, 129.35,
129.53, 129.63, 159.05 (d, J = 240.5 Hz). The reduction of the vinyl
boronic ester was carried out in a similar way to procedures de-
scribed in section 4.2 to give 2-[1-(4-ﬂuorophenyl)ethyl]-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane 1c. Yellow oil, 87%. 1H NMR
(200 MHz, CDCl3): d 1.24 (s, 12H), 1.30 (s, 3 H), 1.61–1.81 (m,
1H), 6.94–7.47 (m, 4H). 13C NMR (50 MHz, CDCl3): d 14.13, 24.79,
83.88, 112.11, 114.72, 128.62, 130.51, 156.51 (d, J = 233.5 Hz).
LRMS (EI) m/z (%) = 248 (M+, 54), 247 (27), 232 (26), 205 (30),
204 (31), 191 (36), 174 (25), 162 (45), 149 (44), 148 (100), 147
(90), 123 (35), 77 (34), 58 (31), 50 (18). FT-IV (ﬁlm, cm1) mmax:
2957, 2918, 2850, 1736, 1635, 1380, 1233, 1181, 835.
4.5. Synthesis of b-borylated carboxylic esters 3a–e
These compounds were synthesized according to the litera-
ture11 and the spectroscopic data are in the literature as well.18
4.6. Synthesis of cyclopropyl boronic esters 5a–c19




Clear oil, 82%. 1H NMR (200 MHz, CDCl3): d 0.25–0.33 (m, 1H),
0.86–1.03 (m, 2H), 1.29 (s, 12H), 2.04–2.10 (m, 1H), 7.03–7.22
(m, 5H). 13C NMR (50 MHz, CDCl3): d 15.05, 21.86, 24.78, 83.31,
125.57, 127.01, 128.19, 128.52, 143.31. LRMS (EI) m/z (%): 245
(13), 244 (M+, 80), 243 (17), 186 (16), 145 (100), 144 (49), 143
(45), 126 (50), 117 (90), 116 (55), 115 (52), 101 (30), 91 (29), 85
Table 2



























































































a Tris buffer 50 mM pH 7.5, DMSO (1%), substrate (10 mM), phosphite (20 mM), PTDH (1 lM), NADPH (0.2 mM), and BVMO (4 lM).
b No reaction was observed.
c No enantiomeric excess was observed.
P. B. Brondani et al. / Tetrahedron: Asymmetry 23 (2012) 703–708 707(25), 83 (27). FT-IV (ﬁlm, cm1) mmax: 3081, 3061, 3026, 2978, 2930,
1624, 1449, 1419, 1353, 1323, 1212, 1144, 969, 852, 750, 697.
4.6.2. 4,4,5,5-Tetramethyl-2-(2-phenylcyclopropyl)-1,3,2-
dioxaborolane 5b
Clear oil, 84%. 1H NMR (200 MHz, CDCl3): d 0.28–0.41 (m, 1H),
0.78 (s, 6 H), 0.91 (s, 6H), 0.95–1.06 (m 1H), 1.14–1.22 (m, 2H),7.00–7.20 (m, 5H). 13C NMR (50 MHz, CDCl3): d 1.02, 8.86, 21.72,
24.35, 24.74, 82.88, 125.67, 127.62, 128.76, 140.70. LRMS (EI) m/z
(%): 245 (15), 244 (M+, 95), 243 (20), 229 (13), 186 (20), 185
(18), 145 (100), 144 (45), 143 (40), 128 (30), 126 (45), 117 (87),
116 (70), 115 (65), 101 (30), 91 (28), 83(25). FT-IV (ﬁlm, cm1)
mmax: 3083, 3060, 3026, 2978, 2927,1603, 1409, 1322, 1223,
1144, 1028, 859, 699.
708 P. B. Brondani et al. / Tetrahedron: Asymmetry 23 (2012) 703–7084.6.3. 4,4,5,5-Tetramethyl-2-(1-phenylcyclopropyl)-1,3,2-
dioxaborolane 5c
Clear oil, 75%. 1H NMR (200 MHz, CDCl3): d 0.87–0.92 (m, 2H),
1.07–1.12 (m, 2H), 1.20 (s, 12H), 7.2–7.51 (m, 5H). 13C NMR
(50 MHz, CDCl3): d 4.02, 13.31, 24.57, 83.29, 125.19, 127.14,
127.93, 128.89, 144.79. LRMS (EI) m/z (%): 245 (15), 244 (M+, 90),
243 (17), 229 (16), 187 (55), 171(18), 145 (97), 144 (77), 143
(75), 129 (29), 117 (100), 116 (65), 115 (59), 105 (50), 101 (60),
85 (42), 83 (44). FT-IV (ﬁlm, cm1) mmax: 3081, 3059, 2978, 2932,
2867, 1685, 1391, 1318, 1145, 849, 699.
4.7. General procedure for enzymatic oxidation reactions
To a ﬂask (2 mL, Eppendorf containing a solution of the start-
ing material (1 M in DMSO, 5 lL) were added Tris/HCl buffer at pH
7.5 (50 mM, 440 lL), phosphite solution (500 mM, 20 lL), NADPH
(100 mM, 10 lL), PTDH (100 lM, 5 lL), and enzyme (BVMO)
(100 lM, 20 lL). Reactions were shaken at 200 rpm and 30 C
(PAMO and M446G PAMO mutant) or 150 rpm and 25 C (HAPMO
and CHMO) for the time established. The reactions were stopped,
extracted with EtOAc (3  0.5 mL), dried over Na2SO4, and ana-
lyzed by chiral HPLC. Control experiments in the absence of an en-
zyme were performed for all substrates tested, and no reaction was
observed.
4.8. General procedure for chemical oxidation of boronic esters
1a–c
To a ﬂask (2 mL, Eppendorf) containing enantiopure boronic
ester 1a–c (0.1 mmol) were added a 2 M NaOH solution (1 mmol)
and H2O2 30% (3 mmol). The reaction was shaken for 3 h at room
temperature. After this period, the reaction was extracted with
EtOAc (3  0.5 mL), dried over Na2SO4, and analyzed by chiral
HPLC.
4.9. Absolute conﬁguration
The absolute conﬁguration of chiral alcohols 2a–c was estab-
lished by comparing HPLC chromatograms with the patterns de-
scribed in the literature.20 The chiral boron compounds 1a–c
were transformed into the corresponding alcohols 2a–c (see Sec-
tion 4.8) to determine their absolute conﬁgurations. The absolute
conﬁguration of compounds 5a–c could not be determined because
the bio-oxidations were not enantioselective.
4.10. Determination of the enantiomeric excess (ee)
The enantiomeric excesses of compounds 2a–c and 5a–c were
measured by chiral HPLC analysis. Compounds 1a–c were trans-
formed into the compounds 2a–c, and then the ee was collected
(see Section 4.8).
The analysis of 2a was carried out on Column Chiracel OD,
n-heptane/iso-propanol 95:5, ﬂow rate: 1 mL/min, UV detection:
254 nm, retention times: tR = 5.00 min (R) and tR = 5.92 min (S).
The analysis of 2b was carried out on Column Chiracel OD-H,
n-heptane/iso-propanol 97:3, ﬂow rate: 0.8 mL/min, UV detection:
227 nm, retention times: tR = 40,54 (S) and 41,93 (R).
The analysis of 2c was carried out on Column Chiralpak AS-H,
n-heptane/iso-propanol 98.5:1.5, ﬂow rate: 0.5 mL/min, UV detec-
tion: 254 nm, retention time: tR = 20,11 (S) and 21,51 (R).The analysis of 5a–c was carried out on Column Chiralpak
AD-H, n-heptane, ﬂow rate: 0.25 mL/min, UV detection: 220 nm.
Retention time of 5a: tR = 20.67 and 22.09; retention time of 5b:
tR = 19.78 and 20.81; retention time of 5c: tR = 17.55 and 19.77.
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